Omni Bio receives grant of new use patent for AAT treatment in Europe

Omni Bio receives grant of new use patent for AAT treatment in Europe

DENVER - Omni Bio Pharmaceutical Inc. (OTCQB: OMBP), a biopharmaceutical company focused on commercialization of new uses of alpha-1 antitrpsin (AAT) for treatment of a variety of medical... Read More

By: InnovatioNews Friday May 9, 2014 0 comments Tags: AAT, Denver, Dr. Bruce Schneider, Fc-AAT

Omni Bio Pharmaceuticals finalizes new $3M credit facility with Bohemian to support operations

Omni Bio Pharmaceuticals finalizes new $3M credit facility with Bohemian to support operations

DENVER - Omni Bio Pharmaceutical Inc. (OTCQB: OMBP) announced the finalization of a private financing arrangement led by its principal investor - Bohemian Investments LLC - that establishes a... Read More

By: InnovatioNews Friday April 25, 2014 0 comments Tags: BOCO Investments, Bohemian Investments, Denver, Fc-AAT

Omni Bio announces favorable results in its lead recombinant molecule

Omni Bio announces favorable results in its lead recombinant molecule

DENVER - Omni Bio Pharmaceutical Inc. (OTCBB: OMBP), a pharmaceutical company focused on commercializing new uses of alpha-1 antitrypsin (AAT) for the treatment of a variety of medical... Read More

By: Steve Monday March 18, 2013 0 comments Tags: AAT, Bruce Schneider, Denver, Fc-AAT